Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Inrig Jula
Over the trailing 90 days, Inrig Jula (Other at Travere Therapeutics, Inc.) traded $1.5M of stock (net selling $567K) in TVTX, per 9 SEC Form 4 transactions.
- Role
- Other
- Companies
- TVTX
- Window
- Trailing 90 days · 9 transactions · CIK 1902368
- Net activity
- −$567K ($448K bought · $1.0M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 9 | $448K | $1.0M | −$567K |
Transactions (9)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-22 | TVTX | Sell | 468 | $0 | Gift (bona fide) |
| 2026-05-06 | TVTX | Sell | 311 | $14K | Open market or private sale |
| 2026-05-05 | TVTX | Sell | 2.2K | $101K | Open market or private sale |
| 2026-05-04 | TVTX | Sell | 20.0K | $900K | Open market or private sale |
| 2026-05-04 | TVTX | Buy | 20.0K | $448K | Exercise or conversion of derivative security |
| 2026-05-04 | TVTX | Buy | 4.2K | $0 | Exercise or conversion of derivative security |
| 2026-05-04 | TVTX | Sell | 4.2K | $0 | Exercise or conversion of derivative security |
| 2026-05-04 | TVTX | Sell | 20.0K | $0 | Exercise or conversion of derivative security |
| 2026-05-04 | TVTX | Buy | 8.5K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Inrig's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.